GGiantBullStocks

Mesa Laboratories, Inc. (MLAB)

NASDAQ · Healthcare

$96.67-1.30%

As of Jul 20, 2026

Price history

Key statistics

Market cap
$522.88M
P/E ratio
EPS
Volume
137,320
52-week high
52-week low
Open
$97.00
Day high
$97.99
Day low
$95.63

Financial highlights

Fiscal yearRevenueNet incomeEPS
2026$249.13M$6.71M$1.21
2025$240.98M-$1.97M-$0.36
2024$216.19M-$254.25M-$47.20
2023$219.08M$930K$0.17
2022$184.34M$1.87M$0.35

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

CEO
Gary Owens
Employees
717
Country
US
IPO date
Feb 29, 1984

Similar stocks

Other Healthcare companies

Frequently asked questions

What is Mesa Laboratories, Inc.'s stock price today?
MLAB is trading at $96.67 as of Jul 20, 2026.
What is Mesa Laboratories, Inc.'s market cap?
Mesa Laboratories, Inc. (MLAB) has a market capitalization of $522.88M.
Does Mesa Laboratories, Inc. pay a dividend?
Yes. In FY2026, Mesa Laboratories, Inc. paid $0.64 per share in dividends.
What sector is Mesa Laboratories, Inc. in?
Mesa Laboratories, Inc. operates in the Healthcare sector.